Moleculin Biotech, Inc.
MBRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001659617
In the last 90 days, Moleculin Biotech, Inc. insiders filed 3 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $518.5K in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Moleculin Biotech, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- +3 vs. Q2 2025
- Shares held
- 778.3K
- +388.6K (+99.7%) vs. Q2 2025
- Total value
- $412.7K
- +$294.8K (+250.0%) vs. Q2 2025
- New holders
- 8
- 5 more added
- Sold out
- 5
- 1 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MBRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 18 | $518.5K |
| Q1 2026 | 20 | $347.9K |
| Q4 2025 | 17 | $315.2K |
| Q3 2025 | 25 | $412.7K |
| Q2 2025 | 22 | $117.9K |
| Q1 2025 | 23 | $1.44M |
| Q4 2024 | 21 | $790.0K |
| Q3 2024 | 19 | $1.31M |
| Q2 2024 | 16 | $1.10M |
| Q1 2024 | 19 | $1.53M |
| Q4 2023 | 24 | $4.44M |
| Q3 2023 | 22 | $925.1K |
| Q2 2023 | 22 | $1.33M |
| Q1 2023 | 23 | $2.91M |
| Q4 2022 | 25 | $3.17M |
| Q3 2022 | 27 | $3.16M |
| Q2 2022 | 26 | $4.32M |
| Q1 2022 | 23 | $5.26M |
| Q4 2021 | 26 | $5.61M |
| Q3 2021 | 24 | $8.57M |
| Q2 2021 | 32 | $10.9M |
| Q1 2021 | 29 | $8.74M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Moleculin Biotech, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 239,919 | $127.2K | 0.00% | +208,984+675.6% | Added |
| Geode Capital Management, LLC | 208,210 | $110.4K | 0.00% | +180,680+656.3% | Added |
| HRT Financial LP | 115,190 | $61.0K | 0.00% | +115,190 | New |
| LPL Financial LLC | 58,080 | $30.8K | 0.00% | +2,000+3.6% | Added |
| Ieq Capital, LLC | 36,363 | $19.3K | 0.00% | +36,363 | New |
| Wealth Dimensions Group, Ltd. | 20,000 | $10.6K | 0.00% | +20,000 | New |
| Rockefeller Capital Management L.P. | 14,506 | $7.69K | 0.00% | +14,506 | New |
| Cambridge Investment Research Advisors, Inc. | 12,781 | $7.00K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 12,752 | $6.76K | 0.00% | +12,752 | New |
| BlackRock, Inc. | 12,380 | $6.56K | 0.00% | 00.0% | Unchanged |
| Truist Financial Corp | 10,500 | $5.57K | 0.00% | 00.0% | Unchanged |
| Ethos Financial Group, LLC | 10,034 | $5.32K | 0.00% | +10,034 | New |
| Moors & Cabot, Inc. | 10,000 | $5.30K | 0.00% | +10,000 | New |
| Tower Research Capital LLC (TRC) | 8,380 | $4.44K | 0.00% | +4,459+113.7% | Added |
| UBS Group AG | 3,965 | $2.10K | 0.00% | −4,024−50.4% | Reduced |
| Newbridge Financial Services Group, Inc. | 2,867 | $1.52K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 926 | $491 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 746 | $395 | 0.00% | 00.0% | Unchanged |
| Bogart Wealth, LLC | 300 | $159 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 266 | $141 | 0.00% | +120+82.2% | Added |
| Advisor Group Holdings, Inc. | 43 | $20 | 0.00% | 00.0% | Unchanged |
| CVA Family Office, LLC | 34 | $18 | 0.00% | 00.0% | Unchanged |
| North Star Investment Management Corp. | 17 | $9 | 0.00% | 00.0% | Unchanged |
| NBC Securities, Inc. | 14 | $7 | 0.00% | +14 | New |
| Royal Bank of Canada | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 0 | $0 | 0.00% | −85,283−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −74,217−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −59,278−100.0% | Sold out |
| Stone House Investment Management, LLC | 0 | $0 | 0.00% | −3,300−100.0% | Sold out |
| Atlantic Union Bankshares Corp | 0 | $0 | 0.00% | −379−100.0% | Sold out |